Skip to main content
. 2017 Oct 23;4(6):e403. doi: 10.1212/NXI.0000000000000403

Figure 3. NK-cell subsets are not influenced by teriflunomide treatment.

Figure 3

NK cells are assessed as CD3CD14CD56bright and CD3CD14CD56dim cells. The percentage of the overall population (A) or the CD56bright and CD56dim subsets (B) did not change on treatment, nor did the actual cell number (C and D, respectively). Data are presented as mean ± SEM for 7 treated patients with MS.